{"id":400256,"date":"2020-08-22T14:16:47","date_gmt":"2020-08-22T11:16:47","guid":{"rendered":"https:\/\/sonna.so\/en\/?p=400256"},"modified":"2020-08-22T14:16:47","modified_gmt":"2020-08-22T11:16:47","slug":"argentina-joins-chinese-coronavirus-vaccine-trial","status":"publish","type":"post","link":"https:\/\/sonna.so\/en\/argentina-joins-chinese-coronavirus-vaccine-trial\/","title":{"rendered":"Argentina joins Chinese coronavirus vaccine trial"},"content":{"rendered":"<p>BEIJING<strong> (SONNA)<\/strong> &#8211; Argentina joined Peru, Morocco and the United Arab Emirates in approving Phase 3 clinical trials for a coronavirus vaccine developed by China National Biotec Group (CNBG), the company said late Friday.<\/p>\n<p>As China forges ahead in the global race to develop a vaccine to curb the COVID-19 pandemic and as cases within China dwindle, CNBG needs research participants from other countries for testing.<\/p>\n<p>Phase 3 trials, which usually involve several thousand participants, allow researchers to gather data on the efficacy of potential vaccines for final regulatory approvals.<\/p>\n<p>CNBG will partner with Argentina\u2019s ELEA in the vaccine trial, the Chinese company said in a statement late Friday.<\/p>\n<p>The experimental vaccine by CNBG, a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), received approval from the UAE in June for a Phase 3 trial and has since recruited 15,000 volunteers.<\/p>\n<p>The company said on Thursday that Peru and Morocco also approved the trials.<\/p>\n<p>CNBG has also obtained approval from Bahrain for a Phase 3 study designed to involve around 6,000 participants.<\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>Reuters\u00a0<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BEIJING (SONNA) &#8211; Argentina joined Peru, Morocco and the United Arab Emirates in approving Phase 3 clinical trials for a coronavirus vaccine developed by China National Biotec Group (CNBG), the company said late Friday. As China forges ahead in the global race to develop a vaccine to curb the COVID-19 pandemic and as cases within [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":400257,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[6,78],"tags":[],"class_list":{"0":"post-400256","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news","8":"category-world"},"_links":{"self":[{"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/posts\/400256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/comments?post=400256"}],"version-history":[{"count":1,"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/posts\/400256\/revisions"}],"predecessor-version":[{"id":400258,"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/posts\/400256\/revisions\/400258"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/media\/400257"}],"wp:attachment":[{"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/media?parent=400256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/categories?post=400256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sonna.so\/en\/wp-json\/wp\/v2\/tags?post=400256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}